Spire Healthcare Group plc Financials

Market Capitalization £917.4 Million as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	38.00
Forward PE	0.15
Price to Sales TTM	£0.61
Price to Book MRQ	£122.58
Enterprise to Revenue	1.41
Enterprise to EBITDA	10.02

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	1.68%
Operating Margin	9.43%
Return on Assets TTM	3.89%
Return on Equity TTM	3.50%

Income Statement

Revenue TTM	£1,511,200,000
Revenue per Share TTM	£3.75
Quarterly Revenue Growth	9.70%
Gross Profit TTM	£683,600,000
EBITDA	£254,300,000
Net Income to Common TTM	£25,400,000
Diluted EPS TTM	£0.06
Quarterly Earnings Growth YoY	-19.50%

Balance Sheet

Total Cash MRQ	£43,700,000
Total Cash per Share MRQ	£0.11
Total Debt MRQ	£
Total Debt to Equity MRQ	171.52
Current Ratio MRQ	0.66
Book Value per Share MRQ	£1.86

Cash Flow

Operating Cash Flow TTM	£235,700,000
Levered Free Cash Flow TTM	£40,825,000

SPI Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	402,363,640
Float Shares	178,033,256
Avg 10 Volume	1,327,075
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	36.44%
% Held by Institutions	47.22%

Stock Price Summary

Beta	0.66
Fifty Two Week Low	£168.20
Fifty Two Week High	£263.00
Fifty Two Week Change	-4.83%
Day 50 MA	£203.90
Day 200 MA	£212.04

Dividends and Splits

Forward Annual Dividend Rate	£9.20
Forward Annual Dividend Yield	4.04%
Trailing Annual Dividend Rate	£2.30
Trailing Annual Dividend Yield	1.01%
Payout Ratio	33.87%
Dividend Date
Ex Dividend Date	2025-05-22
Last Split Factor
Last Split Date